EyePoint Pharmaceuticals vs Tarsier Pharma
EyePoint Pharmaceuticals vs Tarsier Pharma, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: EyePoint Pharmaceuticals is on 36/100 and Tarsier Pharma on 47/100.
Where each one leads
EyePoint Pharmaceuticals
- agent readiness: 50/100 against 21/100
- domain rating: 43/100 against 33/100
- funding raised: $436M against $5.0M
Tarsier Pharma
- our overall score: 47/100 against 36/100
At a glance
| Measure | EyePoint Pharmaceuticals | Tarsier Pharma |
|---|---|---|
| What it is | Ophthalmology-focused biopharmaceutical company developing sustained-release drug delivery systems for serious eye diseases. | Clinical-stage company developing novel treatments for ocular inflammatory blinding diseases. |
| Category | Biotechnology, Biopharmaceuticals, Specialty Pharmaceuticals, Ophthalmology | Healthcare, Disease Treatment, Vision Impairment, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | hardware | services | marketplace | platform | Services |
| Founded | 1987 | 2016 |
| Headquarters | Watertown, United States | Tel Aviv, Israel |
| Status | Inactive | Active |
Size, funding and growth
| Measure | EyePoint Pharmaceuticals | Tarsier Pharma |
|---|---|---|
| Employees | Not published | 12 |
| Headcount growthLast 12 months | Not published | +2.8% |
| Total funding | $436M | $5.0M |
| Latest round | Public Offering | Series B |
| LinkedIn followers | Not published | 1,582 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | EyePoint Pharmaceuticals | Tarsier Pharma |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 36/100 | 47/100 |
| Traction | 40/100 | 45/100 |
| Team | 30/100 | 20/100 |
| Search visibility | 13/100 | 31/100 |
| Quality | 40/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 43/100 | 33/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | EyePoint Pharmaceuticals | Tarsier Pharma |
|---|---|---|
| Hosting | Google Cloud | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Analytics 4 |
EyePoint Pharmaceuticals vs Tarsier Pharma: common questions
Which is better, EyePoint Pharmaceuticals or Tarsier Pharma?
On our 0-100 score Tarsier Pharma rates higher (47/100 against 36/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do EyePoint Pharmaceuticals and Tarsier Pharma compare on the numbers?
EyePoint Pharmaceuticals leads on agent readiness (50/100 against 21/100), domain rating (43/100 against 33/100), funding raised ($436M against $5.0M). Tarsier Pharma leads on our overall score (47/100 against 36/100).
Read the full EyePoint Pharmaceuticals review and pricing or the Tarsier Pharma review and pricing. You can also browse other EyePoint Pharmaceuticals alternatives we track.

